Hooters News: Reuters Health Report

miércoles, 24 de septiembre de 2014

Reuters Health Report

Click to View in Browser

09/24/2014

Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between

U.S. hospitals unprepared to handle Ebola waste

CHICAGO (Reuters) - U.S. hospitals may be unprepared to safely dispose of the infectious waste generated by any Ebola virus disease patient to arrive unannounced in the country, potentially putting the wider community at risk, biosafety experts said.

World risks spending $250 billion just to monitor U.N. development goals

OSLO (Reuters) - The world risks having to spend about $250 billion just to monitor U.N. development targets for 2030, diverting cash from goals such as ending poverty or protecting the environment, according to a study published on Wednesday.

Acorda buys Civitas to gain access to Parkinson's drug

(Reuters) - Acorda Therapeutics Inc said it bought privately held Civitas Therapeutics for $525 million to gain access to a Parkinson's disease drug in late-stage development.

Valeant sees better-than-forecast third-quarter profit

(Reuters) - Valeant Pharmaceuticals Inc expects to report higher-than-expected third-quarter revenue and better-than-forecast adjusted earnings per share, Chief Executive Officer Michael Pearson said on Wednesday.

Gilead's HIV drug shows potential in two mid-stage studies

(Reuters) - Gilead Sciences Inc said its HIV tablet containing tenofovir alafenamide was found better than its approved drug, Stribild, in two mid-stage studies.

Baxter to market Merrimack's cancer drug outside U.S.

(Reuters) - Drug developer Merrimack Pharmaceuticals Inc said it would partner with Baxter International Inc to develop and market its pancreatic cancer drug outside the United States, sending its shares up as much as 27 percent premarket.

Lipocine testosterone therapy meets late-stage study goals

(Reuters) - Lipocine said its treatment for low testosterone met the goals of a late-stage study, sending its shares up 33 percent in premarket trading.

GSK to name Hampton as new chairman this week: source

LONDON (Reuters) - Drugmaker GlaxoSmithKline will this week name Philip Hampton, who currently chairs Royal Bank of Scotland , as its next chairman, a person close to the process said on Wednesday.

U.S. forecasts more than 500,000 Ebola cases in West Africa

NEW YORK/GENEVA (Reuters) - Global experts issued stark new warnings of the scale of West Africa's Ebola outbreak on Tuesday, with the U.S. government estimating between 550,000 and 1.4 million people might be infected in the region by January.

India-Africa trade summit postponed due to Ebola outbreak

NEW DELHI (Thomson Reuters Foundation) - An event aimed at promoting trade and investment between India and Africa has been postponed due to concerns over the deadly Ebola outbreak, India's foreign affairs ministry said on Wednesday.